Search Results for “E_S4HCON2023 Übungsmaterialien – E_S4HCON2023 Lernführung: SAP Certified Technology Specialist – SAP S/4HANA Conversion and SAP System Upgrade – E_S4HCON2023 Lernguide ♿ Suchen Sie auf ⏩ www.itzert.com ⏪ nach 《 E_S4HCON2023 》 und erhalten Sie den kostenlosen Download mühelos 🕑E_S4HCON2023 Online Prüfung” – Page 18

Comparison of pruritus and sensory qualities induced by capsaicin, histamine and cowhage

355	Hawro, T., Lehmann, S., Deuring, E. Weller, K., Altrichter, S., Church, M. K., Maurer, M., and Metz, M.+: Comparison of pruritus and sensory qualities induced by capsaicin, histamine and cowhage. J. Eur. Acad. Dermatol. Venereol. 2019: 33; 1755-1761. IF: 5.25

o.355

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

163

Kaplan, A., Ledford, D., Ashby, M., Canvin, J, Zazzali, J. L., Conner, E., Veith, J., Kamath, N., Staubach, P., Jakob, T., Stirling, R. G., Kuna, P., Berger, W., Maurer, M. and Rosén, K.+: Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J. Allergy Clin. Immunol. 2013: 132; 101-109. IF: 11.25

291	Hawro, T., Ohanyan, T., Schoepke, N., Metz, M., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: Comparison and interpretability of the available urticaria activity scores. Allergy 2018: 73; 251-255. IF: 6.77

25.	Maurer, M. and Cazan, D.: Mastzellen und Frühphasenreaktion. In: Klimek, L., Pfaar, O., Rietschel, E., and Wallstein, E., editors: Allergologie bei Kindern und Jugendlichen. Stuttgart: Schattauer, 2014

151	Cataldi, M., Maurer, M., Taglialatela, M., and Church, M. K.+: Cardiac safety of second-generation H1-antihistamines when updosed in chronic spontaneous urticaria. Clin. Exp. Allergy 2019: 49; 1615-1623. IF: 4.22

r.151

30.	Maurer, M., Dondji, B., and von Stebut, E.: What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis. Med. Microbiol. Immunol. 2009: 198; 137-146. IF: 3.77

154	Vukman, K. V., Adams, P. N., Dowling, D., Metz, M., Maurer, M. and O’Neill, S. M.+: Fasciola hepatica tegumental coat impairs mast cells ability to drive Th1 immune responses. J. Immunol. 2013: 190; 2873-2879. IF: 5.36

168	Krause, K., Kessler, B., Weller, K., Veidt, J., Chen, S. C., Martus, P., Church, M. K., Metz, M., and Maurer, M.+: The German version of ItchyQoL: validation and initial clinical findings. Acta Derm. Venereol. 2013: 93; 562-568. IF: 4.24

o.168

75.	Nelissen, S., Lemmens, E., Geurts, N., Kramer, P., Maurer, M., Hendriks, J., and Hendrix, S.: The role of mast cells in neuroinflammation. Acta Neuropathol. 2013: 125; 637-650. IF: 9.78

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the icatibant outcome survey, a cohort observational study

302

Caballero, T.+, Zanichelli, A., Aberer, W., Maurer, M. Longhurst, H. J., Bouillet, L., and Andresen, I.: Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the icatibant outcome survey, a cohort observational study. Clin. Transl. Allergy 2018: 8; 11. IF: 4.23